What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 years with pulmonary arterial hypertension (PAH)] Contact Protocol code: TREPaed EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Moreno Galdó, Antonio Research group: Creixement i desenvolupament Service: Pediatria General i Especialitats Phase: Fase III Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 2, aleatorizado, abierto y controlado para evaluar la eficacia y la seguridad de rapcabtagene autoleucel frente a un comparador en participantes con miopatías inflamatorias idiopáticas refractarias graves Contact Protocol code: CYTB323L12201 EudraCT code: No aplica Pathology: Malalties del sistema osteomuscular i del teixit connectiu Principal investigator: Selva O'Callaghan, Albert Research group: Malalties sistèmiques Service: Medicina Interna Phase: Fase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS EFFICACY AND SAFETY OF OMECAMTIV MECARBIL IN PATIENTS WITH SYMPTOMATIC HEART FAILURE WITH SEVERELY REDUCED EJECTION FRACTION Contact Protocol code: CY 1033 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Méndez Fernández, Ana Belén Research group: Malalties cardiovasculars Service: Cardiologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, multicéntrico y abierto para evaluar la farmacocinética, la farmacodinamia, la eficacia y la seguridad de Ravulizumab en participantes pediátricos (de 2 a <18 años de edad) con Nefropatía primaria por Inmunoglobulina A (NIgA) Contact Protocol code: ALXN1210-IgAN-325 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Ariceta Iraola, Gema Research group: Fisiopatologia renal Service: Nefrologia Pediàtrica Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado, doble ciego para evaluar la eficacia y laseguridad de CAL101 en pacientes con fibrosis pulmonar idiopática. Contact Protocol code: CAL-101-201 EudraCT code: No aplica Pathology: Diseases of the respiratory system Principal investigator: Villar Gomez, Ana Research group: Pneumologia Service: Pneumologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase 1 open-label trial to evaluate the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of subcutaneous VIS171 in participants with autoimmune disease(s). Contact Protocol code: VIS171-103 EudraCT code: _ Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Sans Atxer, Laia Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 1b que combina dinutuximab beta (DB) con regímenes de quimioterapia de inducción en pacientes con neuroblastoma de alto riesgo de reciente diagnóstico. Contact Protocol code: SIOPEN-PILOT01 EudraCT code: No aplica Pathology: Tumors Principal investigator: Moreno Martín-Retortillo, Lucas Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Phase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45) Contact Protocol code: ENTR-601-45-201 EudraCT code: _ Pathology: Malalties del sistema nerviós Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques Service: General Pediatrics and Specialties Phase: Phase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. AFFIRM: A Randomized, double-blind, placebo-controlled, study to evaluate the effect of Seladelpar on clinical outcomes in patients with primary biliary cholangitis (PBC) and compensated cirrhosis. Contact Protocol code: CB8025-41837 EudraCT code: _ Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Villagrasa Vilella, Ares Aurora Research group: Malalties hepàtiques Service: Hepatologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2025 Títol Complet Service provider of a comprehensive tool for genomic analysis and online biological data interpretation of Pediatric Tumors for the Childhood Cancer and Hematologic Diseases Group of the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient GENOMIC ANALYSIS OF PEDIATRIC TUMORS Codi 24985454 Data publicació Mon, 18 Aug 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ RESOLUTION MODIFY OPENING OF ENVELOPE NO. 1 RESOLUTION 2 MODIFY OPENING OF ENVELOPE NO. 1 RESOLUTION MODIFY OPENING OF ENVELOPE NO. 1, 2 AND 3 TECHNICAL REPORT ACORD ADJUDICACIÓ Professionals Alberto Real Martinez Professionals Andrea Casal Pardo Professionals Mercedes López González Professionals Sandra León Cobos Professionals Eva María Pastor Arroyo Professionals Alfredo Pueyo Ferrer I have been an assistant doctor at the Ophthalmology Department of the Vall d'Hebron Hospital since 2016, where I am dedicated to the medical-surgical pathology of the anterior ocular segment. I am particularly interested in ocular surface and corneal pathology, as well as cataract surgery and intra Year 2025 Títol Complet Servicio de firmas electrónicas para la Unidad de Servicios Jurídico de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient FIRMAS ELECTRÓNICAS VHIR Codi 24985357 Data publicació Thu, 17 Jul 2025 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN INFORME DE VALORACIÓN TÉCNICA RESOLUCIÓN EXCLUSIÓN Y DECLARACIÓN DESIERTO Activities Doctoral thesis Respiratory complications following SARS-CoV-2 infection Doctoral candidate: David Espejo CastellanosDirectors: Dr. María Jesús Cruz Carmona and Dr. Xavier Muñoz GallTutor: Dr. Jaume Ferrer Sancho Activities Tesis doctoral Asthma due to exposure to allergens and other environmental pollutants: inflammatory and immunologic response Doctoral candidate: David Soler SegoviaDirectors: Dr. María Jesús Cruz Carmona and Dr. Xavier Muñoz GallTutor: Dra. María Jesús Cruz Carmona Year 2025 Títol Complet Serveis d'auditoria externa per evidenciar el nivell de compliment dels requisits del sistema de gestió de la qualitat UNE-EN ISO 9001:2015, i la seva posterior adaptació als requisits de la propera nova versió de la norma ISO 9001, si s'escau, a càrrec de la Coordinació de Qualitat, Processos i Gestió documental de la Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR). Expedient SERVEI D’AUDITORIA EXTERNA Codi 24985335 Data publicació Wed, 16 Jul 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1.1 PCAP (word) ANNEX 1.2 PCAP (excel) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT .XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ REQUERIMENT ESMENA ACTA SOBRE ÚNIC ACORD D'ADJUDICACIÓ Pagination First page « Previous page ‹ … Page 313 Page 314 Current page 315 Page 316 Page 317 … Next page › Last page »
Year 2025 Títol Complet Service provider of a comprehensive tool for genomic analysis and online biological data interpretation of Pediatric Tumors for the Childhood Cancer and Hematologic Diseases Group of the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient GENOMIC ANALYSIS OF PEDIATRIC TUMORS Codi 24985454 Data publicació Mon, 18 Aug 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ RESOLUTION MODIFY OPENING OF ENVELOPE NO. 1 RESOLUTION 2 MODIFY OPENING OF ENVELOPE NO. 1 RESOLUTION MODIFY OPENING OF ENVELOPE NO. 1, 2 AND 3 TECHNICAL REPORT ACORD ADJUDICACIÓ
Year 2025 Títol Complet Servicio de firmas electrónicas para la Unidad de Servicios Jurídico de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient FIRMAS ELECTRÓNICAS VHIR Codi 24985357 Data publicació Thu, 17 Jul 2025 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1 PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN INFORME DE VALORACIÓN TÉCNICA RESOLUCIÓN EXCLUSIÓN Y DECLARACIÓN DESIERTO
Year 2025 Títol Complet Serveis d'auditoria externa per evidenciar el nivell de compliment dels requisits del sistema de gestió de la qualitat UNE-EN ISO 9001:2015, i la seva posterior adaptació als requisits de la propera nova versió de la norma ISO 9001, si s'escau, a càrrec de la Coordinació de Qualitat, Processos i Gestió documental de la Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR). Expedient SERVEI D’AUDITORIA EXTERNA Codi 24985335 Data publicació Wed, 16 Jul 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1.1 PCAP (word) ANNEX 1.2 PCAP (excel) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT .XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ REQUERIMENT ESMENA ACTA SOBRE ÚNIC ACORD D'ADJUDICACIÓ
